OpenVSafe by OpenVAERS
Search V-safe

A5J-28874-31014

5 vaccinations 9 coded responses 29 check-ins 9 free-text entries 5 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
750 / TX
Registered
2021-03-02
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
3B8-10947-13103 Child or adolescent in my care · Male · 2021-11-09
LZ3-32815-87605 Child or adolescent in my care · Female · 2022-06-24

Timeline

  1. 2021-03-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-02
    Registered in v-safe
  3. 2021-03-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  4. 2021-03-02
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-03-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Anaphylaxis treatment — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Anaphylaxis reaction 10 minutes after receiving initial vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fever · Chills, Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-03-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fever · Chills
    Adult check-in
  8. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-15
    Survey response — day 14, dose 1
    MedDRA: Diarrhoea, Nausea, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Vomiting, diarrhea, nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-15
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-03-23
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Free text: Shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Trouble sleeping
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-03-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Insomnia — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Trouble sleeping since after receiving shot
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-31
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-20
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-05-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-06
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-09-01
    Dose 3 — Pfizer-BioNTech
  23. 2021-09-21
    Survey response — 6 months, dose 2
    MedDRA: Asthma, Atelectasis, Bronchopulmonary aspergillosis allergic, Hospitalisation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Hospitalized for uncontrolled asthma, Allergic bronchopulmonary aspergillosis, Atelectasis.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-09-21
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  25. 2021-09-22
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  26. 2021-10-02
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  27. 2021-10-06
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  28. 2021-10-13
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  29. 2022-03-03
    Survey response — 6 months, dose 3
    MedDRA: Asthma, Hospitalisation, Pre-existing disease, Tachycardia, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Viral illness leading to hospitalization (5 days) for asthma exacerbation and persistent tachycardia.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-03-03
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  31. 2022-03-04
    Call successful
    Participant prefers to complete VAERS report online
  32. 2022-04-20
    Dose 4 — Pfizer-BioNTech
  33. 2022-09-03
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-09-17
    Dose 5 — Pfizer-BioNTech
  35. 2022-09-18
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  36. 2022-09-19
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  37. 2022-09-20
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  38. 2022-09-23
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  39. 2022-09-24
    Health check-in — day 7, dose 5
    Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  40. 2022-10-02
    Survey response — day 14, dose 5
    MedDRA: Asthma, Oxygen saturation decreased — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Frequent asthma attacks with regular episodes of low ox sat
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-08
    Survey response — day 21, dose 5
    MedDRA: Asthma, Fatigue, Oxygen saturation decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: More frequent and prolonged drops in ox sat. Frequent asthma attacks. Profound exhaustion.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-10-08
    Report sent to call center — day 21, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  43. 2022-10-10
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-03-01Pfizer-BioNTech
22021-03-23Pfizer-BioNTech
32021-09-01Pfizer-BioNTech No
42022-04-20Pfizer-BioNTech No
52022-09-17Pfizer-BioNTech No

Call center

5 call center cases

5 successful

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-03-03

Systemic reaction (other): Anaphylaxis reaction 10 minutes after receiving initial vaccine.

Release 5 — day 14, dose 1

2021-03-15

Symptoms: Vomiting, diarrhea, nausea

Release 6 — days 1–6 daily, dose 2

2021-03-24

Systemic reaction (other): Shortness of breath

2021-03-25

Systemic reaction (other): Trouble sleeping

2021-03-27

Systemic reaction (other): Trouble sleeping since after receiving shot

Release 9 — 6 months, dose 2

2021-09-21

Symptoms: Hospitalized for uncontrolled asthma, Allergic bronchopulmonary aspergillosis, Atelectasis.

Release 11 — 6 months, dose 3

2022-03-03

Symptoms: Viral illness leading to hospitalization (5 days) for asthma exacerbation and persistent tachycardia.

Release 12 — day 14, dose 5

2022-10-02

Symptoms: Frequent asthma attacks with regular episodes of low ox sat

Release 12 — day 21, dose 5

2022-10-08

Symptoms: More frequent and prolonged drops in ox sat. Frequent asthma attacks. Profound exhaustion.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma · · ✓
SDAtelectasis · · ✓
SDBronchopulmonary aspergillosis allergic · · ✓
SDDiarrhoea ✓ ✓ ✓
SDFatigue · · ✓
SDHospitalisation · · ✓
SDNausea ✓ ✓ ✓
SDOxygen saturation decreased · · ✓
SDPre-existing disease · · ✓
SDTachycardia · · ✓
SDViral infection · · ✓
SDVomiting ✓ ✓ ✓
SROAnaphylaxis treatment ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release